Lucia Rose Isham Millham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistance, Multiple, Viral | 1 | 2020 | 52 | 0.670 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 5526 | 0.300 |
Why?
|
| Anti-HIV Agents | 2 | 2020 | 4559 | 0.280 |
Why?
|
| HIV Infections | 5 | 2020 | 17533 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.210 |
Why?
|
| Students, Dental | 1 | 2023 | 170 | 0.190 |
Why?
|
| Beauty Culture | 1 | 2019 | 41 | 0.160 |
Why?
|
| Budgets | 1 | 2020 | 232 | 0.150 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2020 | 164 | 0.150 |
Why?
|
| Hospice Care | 1 | 2023 | 678 | 0.130 |
Why?
|
| Contraception | 1 | 2019 | 361 | 0.130 |
Why?
|
| Universities | 1 | 2020 | 998 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 4058 | 0.120 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 856 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 1737 | 0.100 |
Why?
|
| Students, Medical | 1 | 2023 | 1959 | 0.090 |
Why?
|
| South Africa | 3 | 2020 | 1867 | 0.090 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Masks | 1 | 2020 | 209 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 671 | 0.040 |
Why?
|
| United States | 3 | 2020 | 72903 | 0.040 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2020 | 618 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 223044 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12509 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 2395 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 866 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2023 | 1085 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 1459 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 2587 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65188 | 0.030 |
Why?
|
| HIV | 1 | 2020 | 1585 | 0.030 |
Why?
|
| Male | 5 | 2023 | 363698 | 0.020 |
Why?
|
| Female | 5 | 2023 | 396112 | 0.020 |
Why?
|
| Boston | 1 | 2023 | 9338 | 0.020 |
Why?
|
| Social Support | 1 | 2020 | 2192 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8733 | 0.020 |
Why?
|
| Curriculum | 1 | 2023 | 3782 | 0.020 |
Why?
|
| Humans | 7 | 2023 | 765968 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3139 | 0.020 |
Why?
|
| Palliative Care | 1 | 2023 | 3645 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2904 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2023 | 4863 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7838 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 13024 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 223009 | 0.020 |
Why?
|
| Mass Screening | 1 | 2020 | 5446 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5370 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36386 | 0.010 |
Why?
|
| Young Adult | 1 | 2023 | 59889 | 0.010 |
Why?
|